(Q73227256)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581657%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581657%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

fluticasone propionate

1 reference

J Westbroek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581657%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Saarelainen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581657%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Laher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581657%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J O'Brien

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581657%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Barnacle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581657%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Efthimiou

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581657%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581657%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581657%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581657%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581657%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

689-699

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581657%20AND%20SRC:MED&resulttype=core&format=json

Comparison of Beclomethasone Dipropionate Aerosol and Prednisolone in Reversible Airways Obstruction

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990035-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990035-5

1 reference

7 January 2021

High dose nebulized steroid in the treatment of chronic steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990035-5

7 January 2021

The human pharmacology of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990035-5

7 January 2021

Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990035-5

7 January 2021

Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990035-5

7 January 2021

Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990035-5

7 January 2021

Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990035-5

7 January 2021

Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990035-5

7 January 2021

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990035-5

7 January 2021

Steroid-induced fractures and bone loss in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990035-5

7 January 2021

Inhaled corticosteroids: benefits and risks

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990035-5

7 January 2021

10.1016/S0954-6111(99)90035-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10581657%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference